See more : VIP ComLink, Inc. (VIPK) Income Statement Analysis – Financial Results
Complete financial analysis of Fortive Corporation (FTV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fortive Corporation, a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
- PT Sunindo Pratama Tbk (SUNI.JK) Income Statement Analysis – Financial Results
- Hingham Institution for Savings (HIFS) Income Statement Analysis – Financial Results
- PharmChem, Inc. (PCHM) Income Statement Analysis – Financial Results
- Charter Communications Inc (CQD.DE) Income Statement Analysis – Financial Results
- Datametrex AI Limited (DTMXF) Income Statement Analysis – Financial Results
Fortive Corporation (FTV)
About Fortive Corporation
Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Its Intelligent Operating Solutions segment offers connected reliability tools; environment, health, safety, and quality enterprise software products; facility and asset lifecycle software; pre-construction planning and construction procurement solutions; ruggedized professional test tools; electric, pressure, and temperature calibration tools; and portable gas detection tools for a range of vertical end markets including manufacturing, process industries, healthcare, utilities and power, communications and electronics, and others. It markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The company's Precision Technologies segment provides electrical test and measurement instruments and services; energetic material devices; and sensor and control system solutions for power and energy, medical equipment, food and beverage, aerospace and defense, off-highway vehicles, electronics, semiconductors, and other general industrial markets. This segment markets its products under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands. Its Advanced Healthcare Solutions segment offers hardware and software products and services, including instrument and device reprocessing, instrument tracking, biomedical test tools, radiation safety monitoring, and asset management services; subscription-based surgical inventory management systems to facilitate inventory management and regulatory compliance, as well as technical, analytical, and compliance services to determine radiation exposure services under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.07B | 5.83B | 5.25B | 4.63B | 7.32B | 6.45B | 6.66B | 6.22B | 6.18B | 6.34B | 5.96B | 5.79B |
| Cost of Revenue | 2.47B | 2.46B | 2.25B | 2.03B | 3.64B | 3.13B | 3.36B | 3.19B | 3.18B | 3.29B | 3.10B | 3.02B |
| Gross Profit | 3.59B | 3.36B | 3.01B | 2.61B | 3.68B | 3.32B | 3.30B | 3.03B | 3.00B | 3.05B | 2.86B | 2.76B |
| Gross Profit Ratio | 59.26% | 57.73% | 57.23% | 56.29% | 50.28% | 51.47% | 49.56% | 48.73% | 48.48% | 48.12% | 48.04% | 47.76% |
| Research & Development | 397.80M | 401.50M | 354.80M | 320.70M | 456.70M | 414.30M | 406.00M | 384.80M | 377.70M | 387.60M | 378.30M | 352.70M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.06B | 1.96B | 1.84B | 1.75B | 2.22B | 1.73B | 1.54B | 1.40B | 1.35B | 1.42B | 1.34B | 1.28B |
| Other Expenses | 0.00 | -15.60M | -14.10M | -2.40M | -6.20M | -3.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.46B | 2.36B | 2.19B | 2.07B | 2.68B | 2.14B | 1.94B | 1.79B | 1.73B | 1.80B | 1.72B | 1.64B |
| Cost & Expenses | 4.93B | 4.82B | 4.44B | 4.10B | 6.32B | 5.27B | 5.30B | 4.98B | 4.91B | 5.09B | 4.82B | 4.66B |
| Interest Income | 0.00 | 98.30M | 103.20M | 148.50M | 142.60M | 0.00 | 0.00 | 2.60M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 123.50M | 98.30M | 103.20M | 148.50M | 142.60M | 97.00M | 86.00M | 49.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 456.80M | 465.60M | 395.50M | 384.00M | 341.50M | 260.80M | 158.30M | 176.40M | 176.90M | 178.00M | 159.70M | 145.00M |
| EBITDA | 1.57B | 1.47B | 1.21B | 947.80M | 936.10M | 1.44B | 1.30B | 1.42B | 1.45B | 1.39B | 1.30B | 1.27B |
| EBITDA Ratio | 25.90% | 24.98% | 23.34% | 19.87% | 18.98% | 22.26% | 22.97% | 22.85% | 23.41% | 21.92% | 21.85% | 22.00% |
| Operating Income | 1.13B | 987.40M | 812.80M | 539.40M | 1.00B | 1.18B | 1.35B | 1.25B | 1.27B | 1.25B | 1.14B | 1.13B |
| Operating Income Ratio | 18.69% | 16.95% | 15.47% | 11.64% | 13.72% | 18.26% | 20.36% | 20.02% | 20.55% | 19.65% | 19.18% | 19.49% |
| Total Other Income/Expenses | -142.90M | -113.90M | -135.30M | 968.30M | -107.20M | -100.00M | 141.20M | 135.30M | 0.00 | 33.90M | 0.00 | -42.60M |
| Income Before Tax | 990.80M | 873.50M | 677.50M | 1.51B | 874.50M | 1.08B | 1.28B | 1.20B | 1.27B | 1.28B | 1.14B | 1.13B |
| Income Before Tax Ratio | 16.34% | 14.99% | 12.89% | 32.53% | 11.95% | 16.71% | 19.29% | 19.23% | 20.55% | 20.19% | 19.18% | 19.49% |
| Income Tax Expense | 125.00M | 118.30M | 63.30M | 55.50M | 149.10M | 160.10M | 239.70M | 324.70M | 405.90M | 395.80M | 312.30M | 364.10M |
| Net Income | 865.80M | 755.20M | 608.40M | 1.61B | 738.90M | 2.91B | 1.04B | 872.30M | 863.80M | 883.40M | 830.90M | 763.70M |
| Net Income Ratio | 14.27% | 12.96% | 11.58% | 34.81% | 10.09% | 45.16% | 15.69% | 14.01% | 13.98% | 13.94% | 13.94% | 13.20% |
| EPS | 2.46 | 2.12 | 1.64 | 4.58 | 2.20 | 8.43 | 3.01 | 2.52 | 2.50 | 2.56 | 2.41 | 2.21 |
| EPS Diluted | 2.43 | 2.09 | 1.63 | 4.30 | 2.17 | 8.31 | 2.96 | 2.51 | 2.50 | 2.56 | 2.41 | 2.21 |
| Weighted Avg Shares Out | 352.50M | 356.40M | 349.00M | 337.40M | 335.80M | 345.50M | 347.50M | 345.70M | 345.20M | 345.20M | 345.20M | 345.20M |
| Weighted Avg Shares Out (Dil) | 355.60M | 360.80M | 352.30M | 359.00M | 340.00M | 350.70M | 352.60M | 347.30M | 345.20M | 345.20M | 345.20M | 345.20M |
Fortive Announces Replenishment of Share Repurchase Authorization
Fortive Declares Regular Quarterly Dividend on its Common Stock
5 Technology Stocks Poised to Beat Earnings Estimates in Q4
Allied Digestive Health and Provation Sign Agreement for Enhanced Patient Care
FTV vs. A: Which Stock Should Value Investors Buy Now?
Fortive (FTV) Acquires EA GmbH to Boost Tektronix Business
Fortive Announces Completion of EA Elektro-Automatik Acquisition
Fortive Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
Fortive: Reiterating Buy For A Resilient Business
Fortive: A Good Buy At Current Levels
Source: https://incomestatements.info
Category: Stock Reports